A three-day workshop of invited talks, contributed abstract presentations, hands-on workshops, shared meals and social activities. The outline below shows the four sessions planned for each day. Coffee breaks are not listed separately. Invited speakers are shown with provisional talk titles. The final programme will be published on 19 March 2027.
Wed 19 May 2027
Day 1
Starts at 10:00
09:00–09:45
Registration and coffee
10:00–12:00
Opening and welcome
Introduction and history of alpha therapy
Invited speaker
Øyvind Bruland
The story behind the development of Xofigo
12:00–13:00
Lunch
13:00–14:45
Clinical imaging and non-imaging measurements I
Invited speaker
Pablo Mínguez Gabiña
Clinical imaging of 223Ra
Contributed abstracts
15:00–16:45
Clinical imaging and non-imaging measurements II
Contributed abstracts
Thu 20 May 2027
Day 2
Full day and a shared dinner
08:00–09:45
Biokinetic and pharmacokinetic models
Invited speaker
François Paquet
Benefits and pitfalls of using ICRP publications on occupational intakes of radionuclides for radionuclide therapies
Contributed abstracts
10:00–12:00
Reconstruction
Invited speaker
Peter Bernhardt
Strategies for nuclear medicine image reconstructions for alpha-particle emitters
Contributed abstracts
12:00–13:00
Lunch
13:00–14:45
Small-scale dosimetry, radiobiology and preclinical development
Invited speaker
Asta Juzeniene
Development of new alpha therapies
Contributed abstracts
15:00–16:45
Alpha dosimetry puzzle race
Social event
Evening
Shared dinner
Fri 21 May 2027
Day 3
Ends at 12:00, then lunch
08:00–09:45
Imaging and dosimetry in clinical studies I
Invited speaker
Stephen Graves
Experience from early phase targeted alpha therapy studies with 212Pb
Contributed abstracts
10:00–12:00
Imaging and dosimetry in clinical studies II
Invited speaker
Caroline Stokke
Imaging and dosimetry for alpha emitters: how to plan clinical trials
